Skip to content

Improving Cardiovascular Outcomes: The New Era of Prevention (Hybrid Event)

Improving Cardiovascular Outcomes: The New Era of Prevention (Hybrid Event)

Thursday, June 12, 2025, 7:00 AM

Friday, June 13, 2025, 12:00 PM

Add to Calendar

National Jewish Health - Molly Blank 1400 Jackson Street
Denver, Colorado 80206

The Office of Professional Education
at National Jewish Health
303.398.1000
800.844.2305

Join us for an innovative, two-day educational hybrid conference that redefines what you know about preventing and treating cardiovascular disease. Attendees of this multidisciplinary conference will gain cutting-edge insights into the latest advancements in cardiovascular disease prevention and treatment. Participants will explore new and emerging therapeutic options, including novel lipid-lowering agents, anti-inflammatory approaches, and breakthrough genetic interventions, all with the potential to transform patient care. The conference will also spotlight innovative technologies, such as advanced imaging, AI-driven diagnostics, and wearable health monitoring, equipping clinicians with the tools to enhance early detection and personalize treatment strategies. 

In addition to these advancements, the program will emphasize the critical role of lifestyle interventions in cardiovascular prevention, including nutrition, exercise, stress management, and sleep health. Attendees will develop a deeper understanding of non-traditional and under-recognized risk factors, ensuring a comprehensive, patient-centered approach to risk assessment and management. Featuring leading experts from across the country, this event is designed to bridge the gap between prevention and treatment, empowering clinicians with the latest science, clinical trial data, and evidence-based strategies to improve patient outcomes.

This urgent education will transform the way clinicians treat patients with CVD, leading to lower mortality rates and improved patient outcomes.

Highlights include:

  • Keynote sessions by leading voices in cardiology exploring a unified theory of cardiometabolic renal disease, improved patient outcomes and the future of cardiovascular disease prevention
  • Expert panels on therapeutic advancements, lifestyle medicine, and identifying and mitigating risks
  • Technology spotlights, featuring the latest innovations to leverage in disease prevention

Secure your spot today and be part of this transformative conversation on the future of cardiovascular health.
 

Click Here for Conference Schedule

Add event to calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Program Co-Chairs

Dr. Andrew Freeman (National Jewish Health) is a national leader in lifestyle and preventive cardiology, advocating for plant-based nutrition, exercise, and innovative prevention strategies. 

Dr. Tyler Gluckman (Providence St. Joseph Heart Institute) is a renowned expert in cardiovascular care improvement, analytics, and risk assessment, playing a pivotal role in the development of the ACC/AHA ASCVD Risk Estimator. 

Expert Faculty

Dr. Beth Frates (Harvard Medical School): A member of the Board of Directors of the American College of Lifestyle Medicine, Dr. Frates brings extensive expertise in lifestyle medicine, serving as a part-time associate professor at Harvard Medical School and promoting evidence-based approaches for disease prevention. 

Melinda Benz, RDN (Connected Vegan Melinda Benz, LLC): A registered dietitian nutritionist specializing in plant-based nutrition, Melinda Benz advocates for the power of vegan diets in promoting heart health and overall wellness, providing personalized dietary guidance. 

Dr. Erin Michos (Johns Hopkins Medicine) is a leading authority on women’s heart health and cardiovascular disease prevention, addressing gender disparities in risk assessment, diagnosis, and treatment.
Dr. Marc Bonaca (University of Colorado) is a leading researcher in vascular medicine, atherosclerosis, and clinical trials, advancing the role of novel therapeutics in cardiovascular prevention. 

Dr. Seth Kligerman (National Jewish Health) is a top specialist in cardiovascular imaging, providing critical insights into early detection and noninvasive diagnostics for heart disease. 

Dr. Glenn Hirsch (National Jewish Health) is a nationally recognized leader in cardiovascular research and clinical prevention guidelines, shaping the future of patient care. 
Dr. Seth Martin, MD, MHS Dr. Seth Martin (Johns Hopkins Medicine) focuses at the intersections of digital/mobile health technology, lipidology, cardiovascular risk assessment, health equity, big data and precision medicine.

Dr. Monica Aggarwal (University of Florida) integrates nutrition, lifestyle medicine, and cardiovascular risk reduction, bridging the gap between traditional and integrative cardiology. 

Dr. Chiadi Ndumele (Johns Hopkins Medicine) is Director of Obesity and Cardiometabolic Research and leads research on the intersection of obesity, heart failure prevention, and cardiometabolic disease, with a focus on innovative treatments and public health strategies to reduce cardiovascular risk. 

Dr. Vipin Malik (National Jewish Health) brings a unique perspective on the intersection of pulmonary and cardiovascular health, essential for addressing conditions like sleep medicine and heart-lung interaction. 

 


National Jewish Health is the leading respiratory hospital in the nation. Founded in 1899 as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care.

View full list of Professional Education courses